IL33 and chronic kidney disease: The IL-33 signaling pathway also contributes to fibrosis during the AKI-to-CKD transition by regulating the accumulation of myeloid fibroblast precursors, inflammatory cell infiltration, and the expression of pro-inflammatory cytokines and chemokines [181].